← Back to Search

CLASP for Suicide Prevention (3C Trial)

N/A

Recruiting

Led By Lauren Weinstock, PhD

Research Sponsored by Brown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months after discharge

Awards & highlights

3C Trial Summary

This trial will study whether the Coping Long Term with Active Suicide Program (CLASP) can help reduce suicide risk in veterans.

Who is the study for?

The Veterans Coordinated Community Care (3C) Study is for veterans at least 18 years old who are considered high-risk for suicide after leaving the hospital. They must be able to speak English, make their own decisions, and have access to a phone post-discharge.Check my eligibility

What is being tested?

This study tests if adding the Coping Long Term with Active Suicide Program (CLASP) to usual treatment helps reduce suicide-related behaviors in veterans. Participants will either receive standard care or standard plus CLASP and will be monitored for six months.See study design

What are the potential side effects?

Since this trial involves a psychological support program rather than medication, typical medical side effects are not expected. However, discussing sensitive topics may cause emotional discomfort.

3C Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

3C Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months after discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months after discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

3C Suicide Outcome Measure

Veterans Affairs Healthcare System (VAHS) health and administrative records on suicide related behaviors

Secondary outcome measures

3C Suicidal Ideation and Functioning Outcome Measure

Veterans Affairs Healthcare System (VAHS) health and administrative records on suicidal ideation and functioning

3C Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Coping Long Term with Active Suicide Program (CLASP)Experimental Treatment1 Intervention

The CLASP intervention is an adjunctive, telehealth-based behavioral intervention designed to reduce suicidal behavior among individuals at high risk for suicide going through periods of transition. CLASP is designed to intervene on four risk factor targets: ongoing treatment engagement, problem-solving, social and family support, and hopelessness. In addition to these general factors, the CLASP provider also has the flexibility to identify and target certain "patient-specific" risk factors (e.g., substance misuse) for intervention. CLASP will begin after completion of the baseline assessment, and will continue for 6 months post-discharge. CLASP will be comprised of: a) 3 initial sessions while participants are still inpatients (can occur post-discharge if needed); b) 12 brief telehealth sessions over 6-months post-discharge; c) 6 brief SO telehealth sessions.

Group II: Treatment As Usual (TAU)Active Control1 Intervention

Treatment As Usual (TAU) consists of unrestricted treatment provided as part of routine care in the Veterans Health Administration (VHA) following inpatient hospitalization. Study staff will provide no additional treatment in this arm.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Brown UniversityLead Sponsor

456 Previous Clinical Trials

557,504 Total Patients Enrolled

12 Trials studying Suicide

3,078 Patients Enrolled for Suicide

Harvard UniversityOTHER

229 Previous Clinical Trials

473,655 Total Patients Enrolled

7 Trials studying Suicide

81,100 Patients Enrolled for Suicide

Canandaigua VA Medical CenterFED

12 Previous Clinical Trials

996 Total Patients Enrolled

2 Trials studying Suicide

357 Patients Enrolled for Suicide

Media Library

Suicide Research Study Groups: Coping Long Term with Active Suicide Program (CLASP), Treatment As Usual (TAU)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many locations are participating in this experimental endeavor?

"Patients are welcomed at VA Boston Healthcare System in the state of Massachusetts, Central Arkansas Veterans Healthcare System in Little Rock, and Greater Los Angeles Healthcare System situated in California. Additionally, 9 other sites across America offer enrolment for this clinical trial."

Answered by AI

What is the participation rate of this clinical trial?

"Affirmative, current records hosted on clinicaltrials.gov signal that this investigation is presently enrolling participants. The trial began on the 11th of January 2022 and was last updated the 27th of October 2022. This research requires 850 individuals from 9 separate sites to take part in it."

Answered by AI

Are there still openings for participation in this research endeavor?

"This trial is still recruiting as indicated by clinicaltrials.gov, with the initial posting on 11th January 2022 and most recent update made at the end of October in that same year."

Answered by AI